News
06-26-2018, 04:18 AM
More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells-- known as the PI3 kinase (PI3K) pathway--but efforts to develop therapies targeting this pathway have met with little success after hundreds of mostly failed clinical trials. And researchers still don't understand why.
More... (https://www.news-medical.net/news/20180626/Unbiased-approach-reveals-how-to-restore-breast-cancer-drugse28099-tumor-killing-potential.aspx)
More... (https://www.news-medical.net/news/20180626/Unbiased-approach-reveals-how-to-restore-breast-cancer-drugse28099-tumor-killing-potential.aspx)